Interparfums [IPAR] vs Hims & Hers Health [HIMS] Detailed Stock Comparison

Interparfums Inc.

NASDAQ
Loading...

Hims & Hers Health, Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Interparfums Inc. wins in 17 metrics, Hims & Hers Health, Inc. wins in 3 metrics, with 0 ties. Interparfums Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Interparfums Inc. Hims & Hers Health, Inc. Better
P/E Ratio (TTM) 18.17 55.20 Interparfums Inc.
Price-to-Book Ratio 3.47 11.83 Interparfums Inc.
Debt-to-Equity Ratio 18.82 207.16 Interparfums Inc.
PEG Ratio 1.15 -2.21 Interparfums Inc.
EV/EBITDA 10.78 39.62 Interparfums Inc.
Profit Margin (TTM) 11.31% 5.47% Interparfums Inc.
Operating Margin (TTM) 7.12% 2.72% Interparfums Inc.
EBITDA Margin (TTM) 7.12% 2.72% Interparfums Inc.
Return on Equity 20.34% 25.23% Hims & Hers Health, Inc.
Return on Assets (TTM) 11.28% 5.29% Interparfums Inc.
Free Cash Flow (TTM) $166.70M $57.42M Interparfums Inc.
Dividend Yield 4.25% N/A N/A
1-Year Return -30.72% -53.77% Interparfums Inc.
Price-to-Sales Ratio (TTM) 2.05 2.73 Interparfums Inc.
Enterprise Value $3.19B $6.96B Hims & Hers Health, Inc.
EV/Revenue Ratio 2.14 2.97 Interparfums Inc.
Gross Profit Margin (TTM) 61.46% 71.94% Hims & Hers Health, Inc.
Revenue per Share (TTM) $46 $10 Interparfums Inc.
Earnings per Share (Diluted) $5.24 $0.51 Interparfums Inc.
Beta (Stock Volatility) 1.27 2.32 Interparfums Inc.
Short % of Float 7.92% 38.71% Interparfums Inc.

Interparfums Inc. vs Hims & Hers Health, Inc. Stock Performance Analysis

Loading Price Chart...

IPAR
HIMS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Interparfums Inc.-0.63%-0.93%2.33%-7.42%13.71%7.47%
Hims & Hers Health, Inc.-0.90%15.35%0.88%66.93%-24.24%-17.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Interparfums Inc.-30.72%-28.42%23.33%216.78%342.01%704.52%
Hims & Hers Health, Inc.-53.77%190.56%87.19%166.84%166.84%166.84%

Performance & Financial Health Analysis: Interparfums Inc. vs Hims & Hers Health, Inc.

MetricIPARHIMS
Market Information
Market Cap i$2.92B$6.42B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i214,00945,043,713
90 Day Avg. Volume i273,90634,338,941
Last Close$91.82$27.51
52 Week Range$77.21 - $142.61$13.74 - $70.43
% from 52W High-35.61%-60.94%
All-Time High$161.17 (Apr 17, 2023)$72.98 (Feb 17, 2025)
% from All-Time High-43.03%-62.30%
Growth Metrics
Quarterly Revenue Growth0.07%0.28%
Quarterly Earnings Growth0.16%-0.21%
Financial Health
Profit Margin (TTM) i0.11%0.05%
Operating Margin (TTM) i0.07%0.03%
Return on Equity (TTM) i0.20%0.25%
Debt to Equity (MRQ) i18.82207.16
Cash & Liquidity
Book Value per Share (MRQ)$27.47$2.38
Cash per Share (MRQ)$9.25$2.53
Operating Cash Flow (TTM) i$214.90M$300.01M
Levered Free Cash Flow (TTM) i$99.28M$110.51M
Dividends
Last 12-Month Dividend Yield i4.25%N/A
Last 12-Month Dividend i$4.00N/A

Valuation & Enterprise Metrics Analysis: Interparfums Inc. vs Hims & Hers Health, Inc.

MetricIPAR (Apr 24, 2026)HIMS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i18.1755.20
Forward P/E i17.0819.83
PEG Ratio i1.15-2.21
Price to Sales (TTM) i2.052.73
Price to Book (MRQ) i3.4711.83
Market Capitalization
Market Capitalization i$2.92B$6.42B
Enterprise Value i$3.19B$6.96B
Enterprise Value Metrics
Enterprise to Revenue i2.142.97
Enterprise to EBITDA i10.7839.62
Risk & Other Metrics
Beta i1.272.32
Book Value per Share (MRQ) i$27.47$2.38

Financial Statements Comparison: Interparfums Inc. vs Hims & Hers Health, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIPAR (2025)HIMS (2025)
Revenue/Sales i1.49B2.35B
Cost of Goods Sold i541.29M614.26M
COGS % of Revenue i36.4%26.2%
Gross Profit i947.22M1.73B
Gross Margin i63.6%73.8%
Research & Development iN/A149.30M
Operating Income (EBIT) i270.32M105.61M
Operating Margin i18.2%4.5%
EBITDA i308.66M155.68M
EBITDA Margin i20.7%6.6%
Pre-Tax Income i271.33M123.92M
Pre-Tax Income % of Revenue i18.2%5.3%
Income Tax i63.19M-4.44M
Income Tax % of Revenue i4.2%-0.2%
Net Income (Profit) i208.15M128.37M
Profit Margin i14.0%5.5%

Balance Sheet & Liquidity Metrics

MetricIPAR (2025)HIMS (2025)
Cash & Equivalents i158.09M228.62M
Total Current Assets i1.03B767.64M
Total Current Assets % of Revenue i69.0%32.7%
Total Current Liabilities i344.00M404.43M
Total Current Liabilities % of Revenue i23.1%17.2%
Long-Term Debt i137.22M1.12B
Long-Term Debt % of Revenue i9.2%47.5%
Total Shareholders Equity i1.10B540.93M
Retained Earnings i828.91M-113.77M
Retained Earnings % of Revenue i55.7%-4.8%
Property, Plant & Equipment i115.66M351.33M

Cash Flow Statement Comparison

MetricIPAR (2025)HIMS (2025)
Operating Cash Flow i254.67M400.85M
Operating Cash Flow % of Revenue i17.1%17.1%
Capital Expenditures i-24.41M-226.05M
Free Cash Flow i166.70M57.42M
FCF Margin i11.2%2.4%
Debt Repayment i-50.32MN/A
Common Stock Repurchase i-13.87M-89.96M

Short Interest & Institutional Ownership Analysis

MetricIPARHIMS
Shares Short i1.43M71.36M
Short Ratio i5.151.97
Short % of Float i7.92%38.71%
Shares Outstanding i32.07M227.25M
Float Shares i18.10M207.36M
% Held by Insiders i43.64%5.48%
% Held by Institutions i64.33%85.92%
% Held by Public i-7.97%8.60%

Dividend Analysis & Yield Comparison: Interparfums Inc. vs Hims & Hers Health, Inc.

MetricIPARHIMS
Last 12-Month Dividend i$4.00N/A
Last 12-Month Dividend Yield i4.25%N/A
3-Year Avg Annual Dividend i$3.16N/A
3-Year Avg Dividend Yield i0.62%N/A
3-Year Total Dividends i$9.48N/A
Ex-Dividend DateMar 16, 2026N/A